An experiment was conducted to determine the effect of high dietary intakes of Zn and Cu and their combination on growth performance of weanling pigs with diverse health status and management strategies. Twelve experiment stations cooperated and used a total of 1,356 pigs that averaged 6.55 kg BW and 22.2 d age at weaning. The four dietary treatments, all of which met or exceeded NRC requirements, were 1) control, 2) 3,000 ppm Zn (from Zn oxide), 3) 250 Cu ppm (from Cu sulfate), or 4) 3,000 ppm Zn and 250 ppm Cu. The diets were fed as a complex Phase I diet (1.4% lysine) for 7 d followed by a Phase II diet (1.2% lysine) for 21 d. Chlortetracycline (220 ppm) was added to all diets. Fecal color (1 = yellow to 5 = black) and consistency (1 = very firm to 5 = very watery) were scored daily for 3 wk. At the end of the 28-d study, 412 pigs were bled at five stations, and plasma Cu, Zn, and Fe concentrations were determined at one station with atomic absorption spectrophotometry. Average daily gain (375, 422, 409, 415 g/d), feed intake (637, 690, 671, 681 g/d), and gain/feed (586, 611, 611, 612 g/kg) were improved (P < .01) by the addition of Zn and(or) Cu. Significant Cu x Zn interactions imply that the responses to Zn and Cu were independent and not additive. There were significant (P < .01) Zn and Cu effects and a Zn x Cu interaction on fecal color (3.17, 3.24, 4.32, 3.57) and consistency (2.39, 2.14, 2.14, 2.13). Dietary additions of Cu and Zn resulted in elevated plasma concentrations of Cu and Zn, respectively. These data indicate that pharmacological additions of 3,000 ppm Zn (oxide) or 250 ppm Cu (sulfate) stimulate growth beyond that derived from intakes of Zn and Cu that meet nutrient requirements. However, the combination of Zn and Cu did not result in an additive growth response.
The General Linear Models procedure (PROC GLM) in SAS/STAT software can be programmed to perform the standard statistical analyses used for relative bioavailability studies. The first steps are validity checks to test for statistical validity (linearity), fundamental validity (intersection of regression lines at 0 supplemental level), and equality of the basal diet mean to the point of intersection. The CLASS variable capabilities of PROC GLM can be exploited to expedite these tests. After the validity checks, the GLM procedure can be used to obtain parameter estimates for calculation of relative bioavailability. Optional output provides an inverse matrix to calculate standard errors of slopes and slope ratios. Logarithmic and other transformations of the dependent variable to reduce variance heterogeneity or achieve linearity for subsequent calculation of appropriate bioavailability values also can be accomplished within the SAS System. When nonlinear regression models are more appropriate than linear models, the NLIN procedure can be used.
A study involving nine research stations from the NCR-42 Swine Nutrition Committee used a total of 1,978 crossbred pigs to evaluate the effects of dietary ZnO concentrations with or without an antibacterial agent on postweaning pig performance. In Exp. 1, seven stations (IA, MI, MN, MO, NE, ND, and OH) evaluated the efficacy of ZnO when fed to nursery pigs at 0, 500, 1,000, 2,000, or 3,000 mg Zn/kg for a 28-d postweaning period. A randomized complete block experiment was conducted in 24 replicates using a total of 1,060 pigs. Pigs were bled at the 28-d period and plasma was analyzed for Zn and Cu. Because two stations weaned pigs at < 15 d (six replicates) and five stations at > 20 d (18 replicates) of age, the two sets of data were analyzed separately. The early-weaned pig group had greater (P < 0.05) gains, feed intakes, and gain:feed ratios for the 28-d postweaning period as dietary ZnO concentration increased. Later-weaned pigs also had increased (P < 0.01) gains and feed intakes as the dietary ZnO concentration increased. Responses for both weanling pig groups seemed to reach a plateau at 2,000 mg Zn/kg. Plasma Zn concentrations quadratically increased (P < 0.01) and plasma Cu concentrations quadratically decreased (P < 0.01) when ZnO concentrations were > 1,000 mg Zn/kg. Experiment 2 was conducted at seven stations (KY, MI, MO, NE, ND, OH, and OK) and evaluated the efficacy of an antibacterial agent (carbadox) in combination with added ZnO. The experiment was a 2 x 3 factorial arrangement in a randomized complete block design conducted in a total of 20 replicates. Carbadox was added at 0 or 55 mg/kg diet, and ZnO was added at 0, 1,500, or 3,000 mg Zn/ kg. A total of 918 pigs were weaned at an average 19.7 d of age. For the 28-d postweaning period, gains (P < 0.01), feed intakes (P < 0.05), and gain:feed ratios (P < 0.05) increased when dietary ZnO concentrations increased and when carbadox was added. These responses occurred in an additive manner. The results of these studies suggest that supplemental ZnO at 1,500 to 2,000 mg Zn/kg Zn improved postweaning pig performance, and its combination with an antibacterial agent resulted in additional performance improvements.
Two experiments were conducted to determine the CP concentration below which N retention and growth performance are reduced when low-protein, amino acid-supplemented, corn-soybean meal diets are fed. In a N balance trial (Exp. 1), 12 gilts (initial weight 41 kg) were fitted with urinary catheters and fed six different diets during three 7-d periods in an incomplete block design. The diets were: 1) 18% CP; 2) 14% CP + AA, 3) 16% CP; 4) 12% CP + AA; 5) 14% CP; and 6) 10% CP + AA. Amino acids (lysine, threonine, tryptophan, and methionine) were supplemented such that the concentrations in the low-protein diets were equal to those in their standard (4% CP higher) counterparts. Nitrogen retention (g/d) decreased (P < 0.01) as CP decreased, in both standard (27.10, 24.53, and 20.99) and low-protein (21.51, 19.18, and 15.83) diets, but was lower (P < 0.01) in low-protein diets. There were no differences among treatments (P > 0.05) in biological value (68.2% standard vs 71.0% low-protein). In a growth performance trial (Exp. 2), 36 gilts (initial weight 19.5 kg) were penned individually and fed one of six diets for 35 d in a randomized complete block design. Dietary treatments were a 16% CP standard diet and low-protein diets formulated to contain 15, 14, 13, 12, and 11% CP supplemented with crystalline lysine, tryptophan, threonine, and methionine to equal the total concentrations in the standard diet. Protein concentration affected (P < or = 0.05) ADG, ADFI, feed efficiency, fat-free lean gain, longissimus muscle area, plasma urea, and plasma concentrations of most essential AA. For most of these traits, the major difference was poor performance of pigs fed the 11% CP diet. Thus, in Exp. 1, at AA concentrations from deficient to excess, low-protein, amino acid-supplemented diets failed to produce the same N retention as the equivalent corn-soybean meal diets. However in Exp. 2, the same performance was obtained with 16, 15, 14, 13, and 12% CP. Based on these data, we suggest that N balance is more sensitive than growth to amino acid adequacy andthat other AA (e.g., isoleucine and valine) may limit growth performance when the protein concentration is reduced by more than four percentage units.
A total of 32 select line (SL) and 32 control line (CL) Duroc pigs were used in two trials to determine the effect of dietary amino acid contents during the grower (G) phase and selection for lean growth efficiency on growth performance, carcass traits, and meat quality. In each trial, pigs weighing 20 kg were assigned to 16 pens with two gilts or two castrated males per pen, and pens were randomly assigned within the genetic line to corn-soybean meal G diets formulated to contain 5.0, 7.0, 9.0, or 11.0 g lysine/kg. After 50 kg, all pigs were fed common finisher 1 (F1) and finisher 2 (F2) diets. Pigs were allowed ad libitum access to feed and water. After the initial statistical analyses, the data sets from the two trials were combined. During the G phase, pigs consumed less feed [linear (Ln), P < 0.001] and more lysine (Ln, P < 0.001), grew faster (Ln, P < 0.05) but utilized feed more and lysine less efficiently (Ln, P < 0.001) for weight gain as the amino acid content of G diets increased. Increasing dietary amino acids resulted in less ultrasound backfat (Ln, P < 0.001) and more serum urea nitrogen [Ln, P < 0.001; quadratic (Qd), P < 0.01] at the end of the G phase. Pigs grew more slowly during the F1 (Ln, P < 0.01 and Qd, P = 0.05) and F2 (Ln, P = 0.07) phases and utilized feed and lysine less efficiently (Ln, P < 0.05) for weight gain during the F1 phase as the amino acid content of G diets increased. The grower diet had no effect on overall weight gain and feed efficiency, carcass traits, or meat quality scores. The efficiency of lysine utilization for overall weight gain (Ln, P < 0.001) and lean accretion (Ln, P < 0.05) improved as the amino acid content of G diets decreased. The SL pigs grew faster (P < 0.05) and had less (P < 0.001) ultrasound backfat throughout the study compared with the CL pigs. The SL pigs had less 10th rib backfat (P < 0.001) and tended to have larger longissimus muscle area (P = 0.09) than the CL pigs, which were reflected in greater rate (P < 0.001) and efficiency (P < 0.05) of lean accretion. Marbling (P < 0.05) and meat color (P = 0.07) scores were lower in the SL pigs. No grower diet x genotype interactions were observed in response criteria of interest. The results indicate that pigs subjected to dietary amino acid restrictions during the G phase (as low as 5.0 g lysine/kg) compensated completely in terms of growth rate and body composition regardless of the genotype. Compensatory growth can have a positive impact not only on the overall efficiency of pig production but also on the environment by reducing excretion of unused nutrients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.